Bone Growth Stimulator - your advice?

Sounds like 1:00, and 1:06 up there need to stop bickering about technology and get off their asses and sell. Anyone outside of the corporate mongoloids at training programs understands that the doctors don't give half a shit about bone-stims. They try them out, sometimes are convinced by their results, and then either become a consistent orderer or a 1-3 a year guy. Just sell the shit, bust your ass, treat the patients like gold so you get some positive feedback, and you'll make money. (My experience, at least, in the SW USA)

But can we SSSSTTTOOOPPPPP with the bullshit PEMF vs CMF vs LIpUS bickering? If you can sell like a professional, it shouldn't matter... I could take all of your docs peddling a duracell battery soldered to a coat hanger.

The gospel according to John, thanks be to god.

What a waste of a post. Is it "possible" that we do both? Is it possible to be out there selling in the real world and posting responses on this board? WTF else is there to do on this board besides read rumors and crack jokes. So what if I'm passionate. Get a clue.
 






Why fight about who's product works best? They are all suspect since done in conjunction with cast. Let's continue to overbill Medicare, never offer a rental to the patient as required by law, and wait for dept of justice to come in take all the money back and fine everyone for billing fraud. Better yet, if all the companies stick together, there will be anti trust and price fixing issues to deal with as well. Everybody goes down due to greed. This is corporate America's white collar crime at its best. I hope Blackstone takes these executives to the woodshed. It looks like the Feds are going to do it first. Give the billion dollars back and never bill Medicare again because you can't do it properly.
 






I am looking at an opportunity to sell for the company, mainly the bone growth stimulator. I don't know much about it, except for the research. While it seems like a good idea to me, I'm looking for opinions from anyone that knows the product or sells it.

Is this a good product to sell?

Thank you.

don't sell it...it's a rip off to patients and gov't
 


















ThAt, is the Billion dollar question. Just think how much money in healthcare dollars could be saved by renting. Not so good for the four big companies though....

Thanks for starting a new thread. I have to laugh as people think that BGS is this major expense to the healthcare system. If you look at the total outlay of all ins.carriers and what they payout. $50 billion plus. BGS is about $300mill. a yr tops. That's like comparing $50,000 to .30 cents. It's laughable.
 






Thanks for starting a new thread. I have to laugh as people think that BGS is this major expense to the healthcare system. If you look at the total outlay of all ins.carriers and what they payout. $50 billion plus. BGS is about $300mill. a yr tops. That's like comparing $50,000 to .30 cents. It's laughable.

It was "laughable" enough to get the DOJ's attention and a few greedy people who are pending hefty fines and prison time. It all adds up.
 












It was "laughable" enough to get the DOJ's attention and a few greedy people who are pending hefty fines and prison time. It all adds up.

It is sad to say but the stim business has developed into a pathetic convoluted business that has the label "Unethical" all over it.

Look how Orthofix markets. They use a term called "Marketing Services Agreement" (MSA) as they primary tool. This is nothing more than paying a third party to use their relationships to bring the business. These third parties art typically distributors who have a habit of doing unethical and sometimes illegal maneuvers to bring over the business from their "Relationship Surgeons". Orthofix closes their eyes and pretends they know nothing about what these people do as long as the business comes in. Orthofix is in denial thinking that the MSA protects them from anything illegal or unethical these third party entities do.

Orthofix values this MSA so much they pay more to these third party folks than they pay their own reps. That should tell you something right there about the business. MSA entities need that extra cash to make a profit because they have to do things on their end to make the business a reality.

The business is not about studies, efficacy, or anything at this point. It is about making money by as many people as possible. The MSA people have the opportunity to make the most, management pushes the MSA because they want to keep their job and make money, reps go along with it because they have no choice because in most cases the reps have no surgeon relationships and they want to keep their job. WHAT A JOKE.

So if you want to become an insignificant "Agent" and sign up other people that will control your business that will make more money than you, but you will do all of the work, then it is Great Gig!!
 






Good Grief, who came up with that convoluted plan?? That reaks of bad odor.

Your whole business model is one big joke and a total insult to how healthcare products should be sold.
 












It was "laughable" enough to get the DOJ's attention and a few greedy people who are pending hefty fines and prison time. It all adds up.

What is laughable is the lack of action from Medicare and DOJ..Big biz has continued to hold this market together with all the fraud going on..the profits are so obscene, war chests have been built to pay paultry fines....it really is laughable.
 






I think the people posting here should get their facts straight.

1) bone stimulators do work, i have sold PEMF and Ultrasound devices for many years, i have done numerous patient follow ups and have seen the results

2) OrthoFix was the first BGS company to settle with DJO ( even volunteered to go first in investigation) and have implimented "no tolerance policies" to insure orders are handled ethically

3) OrthoFix recieved its Medicare Certification Letter in Jan 2012, the first BGS company to do so under its new criteria

4) i know some of the other BGS companies will face major challenges as they deal with DJO and Medicare Certification

5) Most doctors do not see differences in BGS as significant, they use whom they have relationships with derived through who gets the the job done right, in a quick reasonable time frame. If the rep communicates with the patient and the medical staff effectively, timing is USUALLY not a issue.
 












I think the people posting here should get their facts straight.

1) bone stimulators do work, i have sold PEMF and Ultrasound devices for many years, i have done numerous patient follow ups and have seen the results

2) OrthoFix was the first BGS company to settle with DJO ( even volunteered to go first in investigation) and have implimented "no tolerance policies" to insure orders are handled ethically

3) OrthoFix recieved its Medicare Certification Letter in Jan 2012, the first BGS company to do so under its new criteria

4) i know some of the other BGS companies will face major challenges as they deal with DJO and Medicare Certification

5) Most doctors do not see differences in BGS as significant, they use whom they have relationships with derived through who gets the the job done right, in a quick reasonable time frame. If the rep communicates with the patient and the medical staff effectively, timing is USUALLY not a issue.


Let's keep this conversation going...
 






This report summarises the efficacy, safety and cost-effectiveness of Exogen bone growth stimulator, a low-intensity ultrasound treatment (LIUS) for the acceleration of bone healing, on the basis of the currently available evidence.

The quality of evidence available for the current review was variable. Only low-level patient case series and registry evidence was available regarding fractures exhibiting non-union. In the case of non-union, no direct comparisons with active interventions such as surgery have been undertaken.

Effectiveness:

On the basis of the evidence currently available, it is not possible to conclude that LIUS is consistently more efficacious than other treatments of fresh fractures. We identified only two high quality, randomised, placebo-controlled studies (Kristiansen et al, 1997;Emami et al, 1999) conducted in distal radius and tibial fractures, respectively. The results of these studies are contradictory.

With respect to the treatment of fractures exhibiting non-union, only poorly controlled patient registry or case series data are currently available. It is concluded that this represents minimally acceptable, low-level evidence to support the efficacy of LIUS for treatment of non-unions.

Recommendation:

We recommended that on the basis of the evidence available on low intensity ultrasound treatment for acceleration of bone fracture healing, public funding should not be supported for this procedure.



ANOTHER GOVERNMENT REVIEW DECIDES EXOGEN = PLACEBO
 






This report summarises the efficacy, safety and cost-effectiveness of Exogen bone growth stimulator, a low-intensity ultrasound treatment (LIUS) for the acceleration of bone healing, on the basis of the currently available evidence.

The quality of evidence available for the current review was variable. Only low-level patient case series and registry evidence was available regarding fractures exhibiting non-union. In the case of non-union, no direct comparisons with active interventions such as surgery have been undertaken.

Effectiveness:

On the basis of the evidence currently available, it is not possible to conclude that LIUS is consistently more efficacious than other treatments of fresh fractures. We identified only two high quality, randomised, placebo-controlled studies (Kristiansen et al, 1997;Emami et al, 1999) conducted in distal radius and tibial fractures, respectively. The results of these studies are contradictory.

With respect to the treatment of fractures exhibiting non-union, only poorly controlled patient registry or case series data are currently available. It is concluded that this represents minimally acceptable, low-level evidence to support the efficacy of LIUS for treatment of non-unions.

Recommendation:

We recommended that on the basis of the evidence available on low intensity ultrasound treatment for acceleration of bone fracture healing, public funding should not be supported for this procedure.



ANOTHER GOVERNMENT REVIEW DECIDES EXOGEN = PLACEBO




More studies and National reviews on Exogen have been published since this OLD review.
 












This report summarises the efficacy, safety and cost-effectiveness of Exogen bone growth stimulator, a low-intensity ultrasound treatment (LIUS) for the acceleration of bone healing, on the basis of the currently available evidence.

The quality of evidence available for the current review was variable. Only low-level patient case series and registry evidence was available regarding fractures exhibiting non-union. In the case of non-union, no direct comparisons with active interventions such as surgery have been undertaken.

Effectiveness:

On the basis of the evidence currently available, it is not possible to conclude that LIUS is consistently more efficacious than other treatments of fresh fractures. We identified only two high quality, randomised, placebo-controlled studies (Kristiansen et al, 1997;Emami et al, 1999) conducted in distal radius and tibial fractures, respectively. The results of these studies are contradictory.

With respect to the treatment of fractures exhibiting non-union, only poorly controlled patient registry or case series data are currently available. It is concluded that this represents minimally acceptable, low-level evidence to support the efficacy of LIUS for treatment of non-unions.

Recommendation:

We recommended that on the basis of the evidence available on low intensity ultrasound treatment for acceleration of bone fracture healing, public funding should not be supported for this procedure.



ANOTHER GOVERNMENT REVIEW DECIDES EXOGEN = PLACEBO

link?
 






Looks like DonJoy is starting to panic because they cant talk about their own product. Nothing new. One of our reps is former DJ and the only thing they are taught in sales training is how to nitpick at Orthofix, Biomet and SN data since they have none of their own to present.